460 related articles for article (PubMed ID: 29806492)
1. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review.
Gomez AF; Barthel AL; Hofmann SG
Expert Opin Pharmacother; 2018 Jun; 19(8):883-894. PubMed ID: 29806492
[TBL] [Abstract][Full Text] [Related]
2. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines.
Mendez EM; Mills JA; Suresh V; Stimpfl JN; Strawn JR
CNS Spectr; 2024 Jun; 29(3):187-196. PubMed ID: 38523533
[TBL] [Abstract][Full Text] [Related]
3. Advances in Pharmacotherapy for Pediatric Anxiety Disorders.
Nicotra CM; Strawn JR
Child Adolesc Psychiatr Clin N Am; 2023 Jul; 32(3):573-587. PubMed ID: 37201968
[TBL] [Abstract][Full Text] [Related]
4. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders: a longitudinal and prospective study.
Benítez CI; Smith K; Vasile RG; Rende R; Edelen MO; Keller MB
Am J Geriatr Psychiatry; 2008 Jan; 16(1):5-13. PubMed ID: 18165458
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review.
Strawn JR; Geracioti L; Rajdev N; Clemenza K; Levine A
Expert Opin Pharmacother; 2018 Jul; 19(10):1057-1070. PubMed ID: 30056792
[TBL] [Abstract][Full Text] [Related]
6. Current and Novel Psychopharmacological Drugs for Anxiety Disorders.
Bandelow B
Adv Exp Med Biol; 2020; 1191():347-365. PubMed ID: 32002937
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis.
Gosmann NP; Costa MA; Jaeger MB; Motta LS; Frozi J; Spanemberg L; Manfro GG; Cuijpers P; Pine DS; Salum GA
PLoS Med; 2021 Jun; 18(6):e1003664. PubMed ID: 34111122
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment for generalized anxiety disorder in adults: an update.
Reinhold JA; Rickels K
Expert Opin Pharmacother; 2015; 16(11):1669-81. PubMed ID: 26159446
[TBL] [Abstract][Full Text] [Related]
11. Selecting pharmacotherapy for generalized anxiety disorder.
Goodman WK
J Clin Psychiatry; 2004; 65 Suppl 13():8-13. PubMed ID: 15384931
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A Meta-Analysis.
Strawn JR; Mills JA; Sauley BA; Welge JA
J Am Acad Child Adolesc Psychiatry; 2018 Apr; 57(4):235-244.e2. PubMed ID: 29588049
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of generalized anxiety disorder.
Reinhold JA; Mandos LA; Rickels K; Lohoff FW
Expert Opin Pharmacother; 2011 Nov; 12(16):2457-67. PubMed ID: 21950420
[TBL] [Abstract][Full Text] [Related]
14. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder.
Castagna PJ; Farahdel E; Potenza MN; Crowley MJ
Expert Opin Pharmacother; 2023 May; 24(7):835-847. PubMed ID: 37074259
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis.
Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G
Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
[TBL] [Abstract][Full Text] [Related]
17. Anxiety Disorders: A Review.
Szuhany KL; Simon NM
JAMA; 2022 Dec; 328(24):2431-2445. PubMed ID: 36573969
[TBL] [Abstract][Full Text] [Related]
18. Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among US Women and Men Before and During the COVID-19 Pandemic.
Milani SA; Raji MA; Chen L; Kuo YF
JAMA Netw Open; 2021 Oct; 4(10):e2131012. PubMed ID: 34694388
[TBL] [Abstract][Full Text] [Related]
19. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
Thorkelson G; Bielefeldt K; Szigethy E
Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
[TBL] [Abstract][Full Text] [Related]
20. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
